Here, we showed that knockdown of CCL21 in GL261 GBM tumor cells prolonged mouse survival in the presence of TMZ-based chemotherapy, whereas TMZ alone was less effective in prolonging mouse survival, and CCL21 knockdown alone had no significant effect on survival or tumor size. Here, CCL21 is linked to glioblastoma.